申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:US06706763B1
公开(公告)日:2004-03-16
O-anisamide compounds and their addition salts effective for the prevention and/or therapy of metabolic diseases such as hyperlipidemia and diabetes, in which peroxisome proliferator-activated receptor (PPAR) being intranuclear receptor, in particular, human PPAR participates, as agonistic drugs thereon, and processes for preparing them, wherein the o-anisamide compounds are represented by a general formula (1)
[wherein R denotes a carboxyl group, carboxymethyl group or CH2CHXCOY (here X denotes a mercapto group or S(O)nMe (n=0, 1 or 2) and Y denotes an amino group or hydroxyl group)], their medicinally acceptable salts, and their hydrates.
O-苯甲酰胺化合物及其加合盐,对于预防和/或治疗代谢性疾病,如高脂血症和糖尿病有效,其中过氧化物酶体增殖物激活受体(PPAR)是细胞核受体,特别是人类PPAR作为其激动剂药物,以及制备它们的方法,其中O-苯甲酰胺化合物由一般式(1)表示[其中R表示羧基,羧甲基或CH2CHXCOY(其中X表示巯基或S(O)nMe(n = 0,1或2),Y表示氨基或羟基)],其药学上可接受的盐和其水合物。